Position in TYRA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$47,149,700
-$28,538,606 QoQ
Shares Held
1,476,196
-25.3% QoQ
Ownership
2.47%
of shares outstanding
% of Portfolio
1.31%
of 13F equity value
Holder Rank
#13
of 169 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in TYRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BVF INC/IL holds $3,440,293,274 across 41 Biotechnology names. TYRA ranks #20 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,965,160 | $555,315,164 | |
| 2 | KYMR |
Kymera Therapeutics, Inc.
|
3,872,052 | $444,008,202 | |
| 3 | MLTX |
MoonLake Immunotherapeutics
|
16,001,284 | $311,544,999 | |
| 4 | GHRS |
GH Research PLC
|
8,650,158 | $232,516,247 | |
| 5 | GPCR |
Structure Therapeutics Inc.
|
3,366,823 | $180,697,390 | |
| 6 | NKTR |
Nektar Therapeutics
|
2,391,075 | $166,920,945 | |
| 7 | MIRM |
Mirum Pharmaceuticals, Inc.
|
1,056,027 | $123,629,080 | |
| 8 | XNCR |
Xencor Inc
|
7,133,720 | $114,852,892 |
All Filings in TYRA
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $47,149,700 | 1,476,196 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $75,688,306 | 1,976,196 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $55,936,312 | 2,127,665 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $51,060,618 | 3,649,794 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $37,745,936 | 3,944,194 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $36,681,004 | 3,944,194 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $54,824,296 | 3,944,194 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $109,584,670 | 4,661,194 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $74,532,492 | 4,661,194 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $76,443,581 | 4,661,194 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $37,943,390 | 2,739,595 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $37,724,223 | 2,739,595 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $46,655,302 | 2,739,595 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $52,060,291 | 3,239,595 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $18,789,685 | 2,472,327 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $21,731,754 | 2,472,327 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $17,677,138 | 2,472,327 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $26,453,898 | 2,472,327 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $26,357,781 | 1,873,332 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $29,813,871 | 1,694,933 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||